Alexandra V.Eberhard

MD EMEA and President Healthcare/Life Sciences Signals Analytics, Partner Cukierman Life Sciences, Expert in digital transformation and innovation

[Scientific American @sciam]

Is CRISPR so “easy to use” that even amateurs can make meaningful contributions to science? (By @aisneed) https://t.co/31iyt8f36e

[Tom Davenport @tdav]

Can Process Robots Deliver #DigitalTransformation?
https://t.co/dEbgWem2tD

[Signals Analytics @SignalsAnalytic]

Have you uncovered the Modern Consumer Decision Journey?
#consumerinsight #marketresearch #marketing https://t.co/1P5WBvi8Mk

[Signals Analytics @SignalsAnalytic]

Introducing the Modern Patient Treatment Journey #patientengagement #mHealth #digitalhealth https://t.co/F79KS1Apob

[Signals Analytics @SignalsAnalytic]

@SignalsAnalytic announces $25M Series C funding, led by @Pitango Growth with existing investors @Sequoia Capital + @Qumra Capital

[Alexandra V.Eberhard @A_V_Eberhard]

@FT very pleased to participate in the panel
"Adopting Open Innovation - Location, Strategies, Risks" at the FT conference this coming week